PET Scan Can Non-Invasively Measure Early Assessment Of Treatment For Common Type Of Breast Cancer, Seattle Cancer Care Alliance And University of Washington Study
ScienceDaily (May 31, 2009) — Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting the first week in June.